Bal Pharma Limited (NSE: BALPHARMA)
India
· Delayed Price · Currency is INR 121.00
-1.95 (-1.59%)
Dec 26, 2024, 3:14 PM IST
Bal Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 26, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,923 | 1,432 | 1,050 | 1,599 | 797 | 461 | Upgrade
|
| Market Cap Growth | 43.57% | 36.34% | -34.31% | 100.65% | 72.70% | -53.83% | Upgrade
|
| Enterprise Value | 3,246 | 2,758 | 2,031 | 2,587 | 1,830 | 1,492 | Upgrade
|
| Last Close Price | 122.16 | 90.39 | 65.76 | 104.78 | 51.65 | 30.68 | Upgrade
|
| PE Ratio | 25.10 | 19.37 | 40.83 | 28.49 | 16.80 | - | Upgrade
|
| PS Ratio | 0.66 | 0.42 | 0.35 | 0.57 | 0.32 | 0.27 | Upgrade
|
| PB Ratio | 3.12 | 2.07 | 1.65 | 2.73 | 1.49 | 1.02 | Upgrade
|
| P/TBV Ratio | 4.02 | 2.23 | 1.79 | 2.93 | 1.60 | 0.95 | Upgrade
|
| P/FCF Ratio | 16.17 | 12.11 | - | 8.72 | 4.20 | 2.54 | Upgrade
|
| P/OCF Ratio | 7.06 | 6.28 | - | 5.97 | 3.57 | 1.98 | Upgrade
|
| EV/Sales Ratio | 1.00 | 0.81 | 0.67 | 0.92 | 0.73 | 0.87 | Upgrade
|
| EV/EBITDA Ratio | 10.60 | 9.49 | 8.54 | 11.77 | 7.49 | 53.09 | Upgrade
|
| EV/EBIT Ratio | 14.44 | 12.31 | 11.66 | 17.33 | 10.81 | - | Upgrade
|
| EV/FCF Ratio | 24.46 | 23.32 | - | 14.12 | 9.64 | 8.21 | Upgrade
|
| Debt / Equity Ratio | 2.28 | 2.05 | 2.09 | 1.82 | 2.12 | 2.68 | Upgrade
|
| Debt / EBITDA Ratio | 5.13 | 4.71 | 5.40 | 4.68 | 4.48 | 33.71 | Upgrade
|
| Debt / FCF Ratio | 11.83 | 12.03 | - | 5.82 | 5.97 | 6.69 | Upgrade
|
| Asset Turnover | 0.97 | 1.07 | 1.06 | 1.12 | 1.05 | 0.68 | Upgrade
|
| Inventory Turnover | 1.86 | 2.12 | 2.07 | 2.55 | 2.41 | 1.28 | Upgrade
|
| Quick Ratio | 0.58 | 0.60 | 0.50 | 0.52 | 0.49 | 0.36 | Upgrade
|
| Current Ratio | 1.12 | 1.15 | 1.09 | 1.11 | 1.08 | 0.99 | Upgrade
|
| Return on Equity (ROE) | 11.64% | 11.20% | 4.29% | 10.20% | 9.55% | -24.43% | Upgrade
|
| Return on Assets (ROA) | 4.20% | 4.43% | 3.80% | 3.73% | 4.42% | -0.68% | Upgrade
|
| Return on Capital (ROIC) | 6.53% | 6.86% | 6.02% | 5.63% | 6.34% | -0.96% | Upgrade
|
| Earnings Yield | 3.88% | 5.16% | 2.45% | 3.51% | 5.95% | -26.49% | Upgrade
|
| FCF Yield | 6.18% | 8.26% | -15.41% | 11.46% | 23.81% | 39.41% | Upgrade
|
| Dividend Yield | 0.88% | 1.33% | 1.52% | 0.95% | 1.94% | - | Upgrade
|
| Payout Ratio | 24.93% | 21.23% | 60.55% | 26.41% | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.47% | -0.73% | -5.86% | -4.39% | -0.19% | - | Upgrade
|
| Total Shareholder Return | 0.47% | 0.59% | -4.34% | -3.43% | 1.75% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.